AMS Posts 29% Revenue Rise for 2025 and Boosts Dividend by 10%
AMS, a UK-based maker of tissue-healing devices, reported preliminary results for 2025 showing 29% revenue growth driven by organic gains and the full-year impact of recent acquisitions. The company delivered a 24% rise in adjusted EBITDA and a 12% increase in adjusted diluted earnings per share. The board has proposed a 10% increase to the full-ye…